The #1 reason GCI has been diminishing in market price is due to GOODWILL. In a business purchase, this represents the excess of amounts paid over the fair value of tangible and other identified intangible assets acquired net of liabilities assumed. It is also the amount of market value items such as brand, reputation, and [...]
Archive for October, 2009
Gannett Co., Inc. – Undervalued
Posted in GCI on October 30, 2009 | 8 Comments »
Did Value Investor Mark Sellers Over-Value PRXI?
Posted in Uncategorized on October 28, 2009 | 1 Comment »
This posting will be short and to the point. My good friend PlanMaestro has written extensively on Premier Exhibitions (PRXI). If you would like to know more about the company and what they do, I suggest you view his blogs here. The purpose of my writing is to show that many value investors, including well [...]
TRID Market Report
Posted in Trident Microsystems, Inc. on October 27, 2009 | Leave a Comment »
TRID’s Tangible Book Value decreased 8.26% from last year balance sheet results. Regardless, the Tangible Book Value is valued at $3.05 per share compared to last year’s results of $3.50 per share. The difference in per share price is -12.88%. Today’s price fluctuation ended down at -12.65%. The interesting thing to make note of is [...]
Equity Risk
Posted in Uncategorized on October 23, 2009 | Leave a Comment »
I sold my position in VXGN today. To sum it up, an activist group of value investors initiated a proxy fight in order to liquidate the company then, recently, the VaxGen company decided to merge itself with another pharma company that was in a worse position financially than VaxGen themselves. This was a classic case [...]
The Wall Of Shame
Posted in Uncategorized on October 16, 2009 | 1 Comment »
Today, I’m adding a new feature to the website entitled ‘The Wall Of Shame’. If anyone would like to contribute to it, please leave a comment listing the company & the reasons why you think it should be included.
The first candidate(s) to make our Wall Of Shame is:
VAXGEN, Inc. (OTC: VXGN)
Vaxgen, Inc. is (was) a [...]
